 |
Inclusion Criteria:
Adverse Events:No adverse events were reported in this trial. Conclusions:There were statistically significant differences between the groups for each of the major Female Sexual Function Index (FSFI)* categories in the differences of means, except improved pain. There were large improvements for questions involving desire, arousal, and orgasms. One explanation for the lack of improved pain responses may be that not many of the subjects reported any baseline level of pain worthy of improvement. Additionally, the overall percent improvement was statistically significant. Study results indicate that this product was effective in boosting female sexual function in this population. Coupled with an extremely low level of medical complaints, it appears that this product may be both effective and safe. 
Two tablets (378mg each) were used during the clinical trial. One tablet (756 mg) is the recommend daily dosage. *FSFI References: Self-Report Assessment of Female Sexual Function: Psychometric Evaluation of the Brief Index of Sexual Functioning for Women * Talyor, J. F., Rosen, R. C., and Leiblum, S. R. * Archives of Sexual Behavior 23 (6), 627-41, 1994 The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function * Rosen, R. Brown, C., et al * Journal of Sex and Marital Therapy 26: 191-208, 2000 AVLIMIL Clinical Trial Prepared November, 2002 by: Marshall-Blum, LLC * Herbal Research Clinic, LLC * James M. Blum, Ph.D., CEO * Adjunct Faculty: University of Maine, Department of Food Sciences and Human Nutrition * Adjunct Faculty: Husson College, College of Arts and Sciences * Cardiac Quality Improvement Consultant, Eastern Maine Medical Center * Member Northern New England Cardiovascular Disease Research Group, Dartmouth-Hitchcock Medical Center * Member Health Services Research Group, Case Western Reserve University, Department of Epidemiology and Biostatistics, Cleveland, Ohio * Ronald I. Blum, M.D. (no relation) These statements have not been reviewed by the Food and Drug Administration, and individual results may vary. Individuals shown are paid models and not necessarily Avlimil users. Avlimil should be taken as part of a healthy lifestyle and is not intended to treat or cure any disease. For telephone orders, please call 1-800-965-3989 *Actual consumer testimonial. Names have been changed to protect the privacy of our consumers. Individual results may vary. |
